Skip to main content
Top
Published in: Journal of Nephrology 2/2024

Open Access 29-11-2023 | Acute Kidney Injury | original Article

Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study

Authors: Natacha Rodrigues, Claudia Costa, Carolina Branco, Carlos Martins, José António Lopes

Published in: Journal of Nephrology | Issue 2/2024

Login to get access

Abstract

Background

Autologous hematopoietic stem cell transplant plays an important role in multiple myeloma (MM) treatment. Increasing incidence of MM and growing awareness of acute kidney injury (AKI) as a complication of hematopoietic stem cell transplant results in the need to better understand AKI in these patients. We aimed to evaluate incidence, risk factors and 5-year prognostic impact of AKI in MM patients undergoing autologous hematopoietic stem cell transplant.

Methods

Retrospective cohort study. AKI was defined by the KDIGO classification using creatinine and urinary output criteria. We used survival analysis methods considering competing events for risk factors and disease-free survival, Cox proportional regression for overall survival and stepwise regression methods for multivariable models.

Results

We analyzed data regarding 143 patients. The cumulative incidence of AKI and moderate-to-severe AKI was 49.7% and 14.1%, respectively. Factors with independent impact on AKI were obesity (HR: 1.83, 95% CI 1.07–3.11; p = 0.026), Hematopoietic cell transplantation—specific comorbidity index (HCT-CI) ≥ 2 (HR: 1.85, 95% CI 1.08–3.17), chronic kidney disease (CKD) (HR: 2.06, 95% CI 1.05–4.04), amyloidosis (HR: 2.25, 95% CI 1.25–4.06), mucositis grade 3–4 (HR: 2.19, 95% CI 1.25–3.86) and exposure to nephrotoxic drugs (HR: 2.0856, 95% CI 1.04–4.19). Moderate-to-severe AKI had an impact (HR: 1.62, 95% CI 1.15–2.31) on 5-year overall survival.

Conclusion

Acute kidney injury affects almost half of MM patients undergoing autologous hematopoietic stem cell transplantation, and reduction in urinary output allows early diagnosis in almost a quarter of the patients. Obesity, HCT-CI ≥ 2, CKD, amyloidosis, mucositis grade 3–4 and exposure to nephrotoxic drugs are significant risk factors. Moderate-to-severe AKI is associated with lower 5-year overall survival.

Graphical abstract

Literature
1.
go back to reference Huang J, Chan SC, Lok V et al (2022) The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol 9:e670–e677CrossRefPubMed Huang J, Chan SC, Lok V et al (2022) The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol 9:e670–e677CrossRefPubMed
2.
go back to reference Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP et al (2018) Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol 4:1221–1227CrossRefPubMedPubMedCentral Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP et al (2018) Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol 4:1221–1227CrossRefPubMedPubMedCentral
4.
go back to reference Gameiro J, Neves J, Rodrigues N, Bekerman C, Melo M, Pereira M et al (2016) Acute kidney injury, long-term renal function and mortality in patients undergoing major abdominal surgery: a cohort analysis. Clin Kidney J 9(2):192–200CrossRefPubMedPubMedCentral Gameiro J, Neves J, Rodrigues N, Bekerman C, Melo M, Pereira M et al (2016) Acute kidney injury, long-term renal function and mortality in patients undergoing major abdominal surgery: a cohort analysis. Clin Kidney J 9(2):192–200CrossRefPubMedPubMedCentral
5.
go back to reference Pereira M, Rodrigues N, Godinho I, Gameiro J, Neves M, Gouveia J et al (2017) Acute kidney injury in patients with severe sepsis or septic shock: a comparison between the ‘risk, injury, failure, loss of kidney function, end-stage kidney disease’ (RIFLE), acute kidney injury network (AKIN) and kidney disease: improving global outcomes (KDIGO) classifications. Clin Kidney J 10(3):332–340PubMed Pereira M, Rodrigues N, Godinho I, Gameiro J, Neves M, Gouveia J et al (2017) Acute kidney injury in patients with severe sepsis or septic shock: a comparison between the ‘risk, injury, failure, loss of kidney function, end-stage kidney disease’ (RIFLE), acute kidney injury network (AKIN) and kidney disease: improving global outcomes (KDIGO) classifications. Clin Kidney J 10(3):332–340PubMed
6.
go back to reference Kidney disease: improving global outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2(1):1–138 Kidney disease: improving global outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2(1):1–138
7.
go back to reference Kanduri SR, Cheungpasitporn W, Thongprayoon C, Kovvuro K, Garla V, Medaura J et al (2020) Incidence and mortality of acute kidney injury in patients undergoing hematopoetic stem cell transplantation: a systematic review and meta-analysis. QJM 113(9):621CrossRefPubMedPubMedCentral Kanduri SR, Cheungpasitporn W, Thongprayoon C, Kovvuro K, Garla V, Medaura J et al (2020) Incidence and mortality of acute kidney injury in patients undergoing hematopoetic stem cell transplantation: a systematic review and meta-analysis. QJM 113(9):621CrossRefPubMedPubMedCentral
8.
go back to reference Gutiérrez-García G, Villarreal J, Garrote M, Rovira M, Blasco M, Suárez-Lledó M et al (2020) Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis. Bone Marrow Transplant 55(7):1264–1271CrossRefPubMed Gutiérrez-García G, Villarreal J, Garrote M, Rovira M, Blasco M, Suárez-Lledó M et al (2020) Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis. Bone Marrow Transplant 55(7):1264–1271CrossRefPubMed
9.
go back to reference Sakaguchi M, Nakayama K, Yamaguchi H, Mii A, Shimizu A, Inai K et al (2020) Risk factors for acute kidney injury and chronic kidney disease following allogeneic hematopoietic stem cell transplantation for hematopoietic malignancies. Acta Haematol 143:452–464CrossRefPubMed Sakaguchi M, Nakayama K, Yamaguchi H, Mii A, Shimizu A, Inai K et al (2020) Risk factors for acute kidney injury and chronic kidney disease following allogeneic hematopoietic stem cell transplantation for hematopoietic malignancies. Acta Haematol 143:452–464CrossRefPubMed
10.
go back to reference Andronesi A, Sorohan B, Burcea A, Lipan L, Stanescu C, Cracium O et al (2022) Incidence and risk factors for acute kidney injury after allogeneic stem cell transplantation: a prospective study. Biomedicines 10:262CrossRefPubMedPubMedCentral Andronesi A, Sorohan B, Burcea A, Lipan L, Stanescu C, Cracium O et al (2022) Incidence and risk factors for acute kidney injury after allogeneic stem cell transplantation: a prospective study. Biomedicines 10:262CrossRefPubMedPubMedCentral
11.
go back to reference Rodrigues N, Costa C, Branco C, Marques F, Vasconcelos P, Martins C et al (2023) Acute kidney injury in patients with leukaemia submitted to allogeneic hematopoietic stem cell transplant – KDIGO classification with creatinine and urinary output criteria: cohort analysis. Clin Oncol 6(18):1–10 Rodrigues N, Costa C, Branco C, Marques F, Vasconcelos P, Martins C et al (2023) Acute kidney injury in patients with leukaemia submitted to allogeneic hematopoietic stem cell transplant – KDIGO classification with creatinine and urinary output criteria: cohort analysis. Clin Oncol 6(18):1–10
12.
go back to reference Rodrigues N, Branco C, Costa C, Marques F, Neves M, Vasconcelos P et al (2023) Acute kidney injury in autologous hematopoietic stem cell transplant for patients with lymphoma - KDIGO classification with creatinine and urinary output criteria: a cohort analysis. Ren Fail 45(1):2183044CrossRefPubMedPubMedCentral Rodrigues N, Branco C, Costa C, Marques F, Neves M, Vasconcelos P et al (2023) Acute kidney injury in autologous hematopoietic stem cell transplant for patients with lymphoma - KDIGO classification with creatinine and urinary output criteria: a cohort analysis. Ren Fail 45(1):2183044CrossRefPubMedPubMedCentral
13.
go back to reference Andronesi AG, Tanase AD, Sorohan BM, Craciun OG, Stefan L, Varady Z et al (2019) Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma. Cancer Med 8(6):3278–3285CrossRefPubMedPubMedCentral Andronesi AG, Tanase AD, Sorohan BM, Craciun OG, Stefan L, Varady Z et al (2019) Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma. Cancer Med 8(6):3278–3285CrossRefPubMedPubMedCentral
15.
go back to reference Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J et al (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67(6):2089–2100CrossRefPubMed Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J et al (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67(6):2089–2100CrossRefPubMed
16.
go back to reference Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538-548CrossRefPubMed Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538-548CrossRefPubMed
17.
go back to reference Greipp P, Miguel J, Durie B, Crowley J, Bladé J, Boccadoro M et al (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412–3420CrossRefPubMed Greipp P, Miguel J, Durie B, Crowley J, Bladé J, Boccadoro M et al (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412–3420CrossRefPubMed
18.
go back to reference Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912–2919CrossRefPubMedPubMedCentral Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912–2919CrossRefPubMedPubMedCentral
19.
go back to reference Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign guidelines committee including the pediatric subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Crit Care Med 41:580–637CrossRefPubMed Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign guidelines committee including the pediatric subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Crit Care Med 41:580–637CrossRefPubMed
20.
go back to reference Quinn B, Stone R, Uhlenhopp M, McCann S, Blijlevens N (2007) Ensuring accurate oral mucositis assessment in the European Group for Blood and Marrow Transplantation Prospective Oral Mucositis Audit. Eur J Oncol Nurs 11(Suppl 1):S10-18CrossRefPubMed Quinn B, Stone R, Uhlenhopp M, McCann S, Blijlevens N (2007) Ensuring accurate oral mucositis assessment in the European Group for Blood and Marrow Transplantation Prospective Oral Mucositis Audit. Eur J Oncol Nurs 11(Suppl 1):S10-18CrossRefPubMed
21.
go back to reference Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509CrossRef Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509CrossRef
22.
go back to reference Iacobelli S, Committee ES (2013) Suggestions on the use of statistical methodologies in studies of the European group for blood and marrow transplantation. Bone Marrow Transpl 48:S1-37CrossRef Iacobelli S, Committee ES (2013) Suggestions on the use of statistical methodologies in studies of the European group for blood and marrow transplantation. Bone Marrow Transpl 48:S1-37CrossRef
23.
go back to reference Caliskan Y, Besisik SK, Sargin D, Ecder T (2006) Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation. Bone Marrow Transplant 38(2):141–147CrossRefPubMed Caliskan Y, Besisik SK, Sargin D, Ecder T (2006) Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation. Bone Marrow Transplant 38(2):141–147CrossRefPubMed
24.
go back to reference Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M et al (2003) Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int 63(5):1868–1873CrossRefPubMed Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M et al (2003) Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int 63(5):1868–1873CrossRefPubMed
25.
go back to reference Merouani A, Shpall EJ, Jones RB, Archer PG, Schrier RW (1996) Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int 50(3):1026–1031CrossRefPubMed Merouani A, Shpall EJ, Jones RB, Archer PG, Schrier RW (1996) Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int 50(3):1026–1031CrossRefPubMed
26.
go back to reference Gameiro J, Gonçalves M, Pereira M, Rodrigues N, Godinho I, Neves M et al (2018) Obesity, cute kidney injury and mortality in patients with sepsis: a cohort analysis. Ren Fail 40(01):120–126CrossRefPubMedPubMedCentral Gameiro J, Gonçalves M, Pereira M, Rodrigues N, Godinho I, Neves M et al (2018) Obesity, cute kidney injury and mortality in patients with sepsis: a cohort analysis. Ren Fail 40(01):120–126CrossRefPubMedPubMedCentral
27.
28.
go back to reference Nakamuro K, Fuster J, Walsh K (2014) Adipokines: a link between obesity and cardiovascular disease. J Cardiol 63:250–259CrossRef Nakamuro K, Fuster J, Walsh K (2014) Adipokines: a link between obesity and cardiovascular disease. J Cardiol 63:250–259CrossRef
29.
go back to reference Pasquini M, Logan B, Vincent T, McCarthy PL Jr, Kenneth C et al (2012) Comorbidity index (CI) in autologous hematopoietic cell transplantation (HCT) for malignant diseases validation of the HCT-CI. Blood 120:814CrossRef Pasquini M, Logan B, Vincent T, McCarthy PL Jr, Kenneth C et al (2012) Comorbidity index (CI) in autologous hematopoietic cell transplantation (HCT) for malignant diseases validation of the HCT-CI. Blood 120:814CrossRef
Metadata
Title
Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study
Authors
Natacha Rodrigues
Claudia Costa
Carolina Branco
Carlos Martins
José António Lopes
Publication date
29-11-2023
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 2/2024
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-023-01809-3

Other articles of this Issue 2/2024

Journal of Nephrology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine